IRIS Accounts Production v25.4.0.155 00987160 Board of Directors 1.7.24 30.6.25 30.6.25 true true false true true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh009871602024-06-30009871602025-06-30009871602024-07-012025-06-30009871602023-06-30009871602023-07-012024-06-30009871602024-06-3000987160ns15:EnglandWales2024-07-012025-06-3000987160ns14:PoundSterling2024-07-012025-06-3000987160ns10:Director12024-07-012025-06-3000987160ns10:PublicLimitedCompanyPLC2024-07-012025-06-3000987160ns10:FRS1022024-07-012025-06-3000987160ns10:Audited2024-07-012025-06-3000987160ns10:LargeCompaniesRegimeForDirectorsReport2024-07-012025-06-3000987160ns10:LargeCompaniesRegimeForAccounts2024-07-012025-06-3000987160ns10:FullAccounts2024-07-012025-06-300098716012024-07-012025-06-3000987160ns10:OrdinaryShareClass12024-07-012025-06-3000987160ns10:Director22024-07-012025-06-3000987160ns10:Director32024-07-012025-06-3000987160ns10:CompanySecretary12024-07-012025-06-3000987160ns10:RegisteredOffice2024-07-012025-06-3000987160ns10:Director42024-07-012025-06-3000987160ns5:CurrentFinancialInstruments2025-06-3000987160ns5:CurrentFinancialInstruments2024-06-3000987160ns5:ShareCapital2025-06-3000987160ns5:ShareCapital2024-06-3000987160ns5:RetainedEarningsAccumulatedLosses2025-06-3000987160ns5:RetainedEarningsAccumulatedLosses2024-06-3000987160ns5:ShareCapital2023-06-3000987160ns5:RetainedEarningsAccumulatedLosses2023-06-3000987160ns5:RetainedEarningsAccumulatedLosses2023-07-012024-06-3000987160ns5:RetainedEarningsAccumulatedLosses2024-07-012025-06-300098716042024-07-012025-06-300098716042023-07-012024-06-3000987160ns5:IntangibleAssetsOtherThanGoodwill2024-07-012025-06-3000987160ns5:LongLeaseholdAssetsns5:LandBuildings2024-07-012025-06-3000987160ns5:PlantMachinery2024-07-012025-06-3000987160ns5:FurnitureFittings2024-07-012025-06-3000987160ns5:MotorVehicles2024-07-012025-06-3000987160ns5:ComputerEquipment2024-07-012025-06-3000987160ns10:HighestPaidDirector2024-07-012025-06-3000987160ns10:HighestPaidDirector2023-07-012024-06-3000987160ns5:OwnedAssets2024-07-012025-06-3000987160ns5:OwnedAssets2023-07-012024-06-300098716012024-07-012025-06-300098716012023-07-012024-06-3000987160ns10:OrdinaryShareClass12023-07-012024-06-3000987160ns5:PatentsTrademarksLicencesConcessionsSimilar2024-06-3000987160ns5:PatentsTrademarksLicencesConcessionsSimilar2025-06-3000987160ns5:PatentsTrademarksLicencesConcessionsSimilar2024-06-3000987160ns5:LongLeaseholdAssetsns5:LandBuildings2024-06-3000987160ns5:PlantMachinery2024-06-3000987160ns5:FurnitureFittings2024-06-3000987160ns5:LongLeaseholdAssetsns5:LandBuildings2025-06-3000987160ns5:PlantMachinery2025-06-3000987160ns5:FurnitureFittings2025-06-3000987160ns5:LongLeaseholdAssetsns5:LandBuildings2024-06-3000987160ns5:PlantMachinery2024-06-3000987160ns5:FurnitureFittings2024-06-3000987160ns5:MotorVehicles2024-06-3000987160ns5:ComputerEquipment2024-06-3000987160ns5:MotorVehicles2025-06-3000987160ns5:ComputerEquipment2025-06-3000987160ns5:MotorVehicles2024-06-3000987160ns5:ComputerEquipment2024-06-3000987160ns5:CostValuation2024-06-3000987160ns5:Subsidiary22024-07-012025-06-3000987160ns5:Subsidiary232024-07-012025-06-3000987160ns5:Subsidiary22025-06-3000987160ns5:Subsidiary22024-06-3000987160ns5:Subsidiary22023-07-012024-06-3000987160ns5:Subsidiary32024-07-012025-06-30009871605ns5:Subsidiary32024-07-012025-06-3000987160ns5:Subsidiary32025-06-3000987160ns5:Subsidiary32024-06-3000987160ns5:Subsidiary32023-07-012024-06-3000987160ns5:WithinOneYearns5:CurrentFinancialInstruments2025-06-3000987160ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3000987160ns5:WithinOneYear2025-06-3000987160ns5:WithinOneYear2024-06-3000987160ns5:BetweenOneFiveYears2025-06-3000987160ns5:BetweenOneFiveYears2024-06-3000987160ns5:MoreThanFiveYears2025-06-3000987160ns5:MoreThanFiveYears2024-06-3000987160ns5:AllPeriods2025-06-3000987160ns5:AllPeriods2024-06-3000987160ns5:DeferredTaxation2024-07-012025-06-3000987160ns5:DeferredTaxation2025-06-3000987160ns10:OrdinaryShareClass12025-06-3000987160ns5:RetainedEarningsAccumulatedLosses2024-06-30
REGISTERED NUMBER: 00987160 (England and Wales)














Strategic Report, Report of the Directors and

Financial Statements

for the Year Ended 30th June 2025

for

Cirrus Research plc

Cirrus Research plc (Registered number: 00987160)






Contents of the Financial Statements
for the year ended 30th June 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 6

Report of the Independent Auditors 8

Statement of Comprehensive Income 12

Balance Sheet 13

Statement of Changes in Equity 14

Cash Flow Statement 15

Notes to the Cash Flow Statement 16

Notes to the Financial Statements 17


Cirrus Research plc

Company Information
for the year ended 30th June 2025







DIRECTORS: K D Frankish
D S Wallis
L M Wallis



SECRETARY: M Worrall



REGISTERED OFFICE: Acoustic House
Bridlington Road
Hunmanby
North Yorkshire
YO14 0PH



REGISTERED NUMBER: 00987160 (England and Wales)



AUDITORS: Sadofskys
Statutory Auditors
Princes House
Wright Street
Hull
East Yorkshire
HU2 8HX



BANKERS: National Westminster Bank Plc
3 Westborough
Scarborough
North Yorkshire
YO11 1UH

Cirrus Research plc (Registered number: 00987160)

Strategic Report
for the year ended 30th June 2025

The directors present their strategic report for the year ended 30th June 2025.

REVIEW OF BUSINESS
The key financial highlights are as follows:


30/06/25 30/06/24 30/06/23 30/06/22
£ £ £ £
Revenue 6,081,043 4,877,275 4,774,327 4,324,271
Revenue - Growth 24.68% 2.16% 10.43% 0.64%
Profit before tax 657,722 13,125 209,753 157,971
Profit before tax margin 10.81% 0.27% 4.39% 3.65%


Our overall sales have continued to grow throughout the year by 24.68%. This was helped by a modest price increase which was used to absorb the rising costs in our supply chain. The overall performance of the year has resulted in a surplus of £658k.

While the overall headcount remained much the same, we continue to invest in our team. An annual salary increase was awarded in January, and we have recently seen several internal promotions and training provided to enhance the skill set of future leaders.

Our order book continues to be healthy and our expectations for 2025/2026 are very positive.

PRINCIPAL RISKS AND UNCERTAINTIES
As an exporter, we remain acutely aware that ongoing global economic volatility including inflationary pressures, shifting interest rate regimes, and persistent geopolitical uncertainties can adversely affect international trade and, by extension, our business operations. In response, our strategy continues to focus on reducing business risk, ensuring we are not overly reliant on any single sector or geography.

We recognise that regulatory frameworks are evolving rapidly across jurisdictions, often in response to new trade agreements, environmental mandates, and data security concerns. We proactively ensure that our products and processes remain fully compliant with applicable regulations in every country in which we operate.

The company remains vigilant in identifying and mitigating key financial risks such as credit exposure, foreign exchange fluctuations, cybersecurity threats, and emerging forms of fraud. To address these, we have in place a robust and responsive risk management framework aligned with current best practices.

Given the company's relatively small scale and streamlined organisational structure, a formal sub-committee of the Board of Directors for risk oversight is not deemed necessary at this time. However, the Board has issued comprehensive policy guidelines empowering operational teams to identify, assess, and manage risks effectively across all functions.

Credit Risk
The company's exposure to credit risk continues to be at moderate level and is managed through a mix of initiatives such as entering into legally sound and enforceable agreements and monitoring of credit exposure within the limits fixed for various customers. The doubtful debts arising out of factors like dealer closure are immediately recognised and provided for in the accounts.

Fraud Risk
The company adopts a proactive approach to mitigating fraud risk through a combination of internal controls, staff training, and technology-driven monitoring systems. We have established clear policies and procedures to ensure transparency, accountability, and segregation of duties across all financial and operational functions. Regular audits both internal and external help identify potential vulnerabilities and reinforce compliance. Employees are trained to recognise and report suspicious activities. Additionally, we leverage secure digital platforms and transaction monitoring tools to detect anomalies in real time, reducing the likelihood of financial misconduct or data breaches. This comprehensive approach ensures that fraud risk is continuously assessed and effectively managed across the organisation.


Cirrus Research plc (Registered number: 00987160)

Strategic Report
for the year ended 30th June 2025

SECTION 172(1) STATEMENT
The Board of Directors, in accordance with their duties under Section 172 of the Companies Act 2006, act in good faith and in a manner they consider most likely to promote the success of the Company for the benefit of its members as a whole. In doing so, they take into account a range of factors when making decisions with a long-term perspective. Key strategic decisions and matters of importance to the Company are informed by these Section 172 considerations.

At Cirrus Research plc, our Board of Directors, management, and employees are committed to upholding high standards of corporate governance and business ethics. We believe that timely disclosures, transparent accounting policies, rigorous internal controls, and a strong, independent Board are fundamental to maintaining shareholder trust while maximising long-term shareholder value.

This s172 statement explains how the Cirrus Directors:

- Have engaged with employees, suppliers, customers and others; and
- Have given due regards to employee interests, the importance of fostering business relationships with suppliers, customers and others, and the impact of this regard on the principal decisions taken by the Company during the financial year.

The s172 statement focuses on matters of strategic importance to Cirrus, and the level of information disclosed is consistent with the size and the complexity of the business.

General confirmation of Directors' duties
Cirrus have a number of management teams appointed by the Board at group level to focus on specific areas and take informed decisions within the framework of delegated authority, and make specific recommendations to the Board. All decisions and recommendations of the committees are placed before the Board for information or for approval.

When making decisions, each Director ensures that they act in the way they consider, in good faith, would most likely promote the Company' success for the benefit of its members as a whole, and in doing so have regard (among matters) to:

The likely consequences of any decision in the long term
The Directors understand the business and the demand to innovate the latest products in order to find the most effective treatments in the company's core markets. Cirrus' vision and goal of customer satisfaction is what the business drives and strives for. The strategy set by the Board as a leader in the noise measurement industry is to ensure good health can be delivered to those who need it, and to promote wellness among them.

Whilst investing for the future, the Board also recognises that we must focus on meeting the current supply and demand of its products. The Directors are guided by our core principles which provide both guidance for our current behaviour and inspiration for our future actions.

The interests of the company's employees
At Cirrus its employees are at the heart of our business. The Management team invites a fair and open two-way relationship with all employees. We believe in respecting every individual, regardless of position. At Cirrus all employees are heard and have the opportunity to express their opinion. The organisation believes in equality and discourage any discrimination based on any caste, creed, race, religion age and gender etc. We are committed to employee's safety and well-being. Our HR policies are well documented and available to each employee. Management assumes responsibility that such policies are adhered to.

The talented and capable people have played a major role in powering and defining the growth of Cirrus. We believe that when people with diverse skills are bound together by a common purpose and value system, they can allow the company to achieve its aims.

The need to foster the company's business relationships with suppliers, customers and others
Customers and suppliers are the key stakeholders in our business. In a competitive price driven environment, stock is the vital component at the keenest price. We engage in regular communication with our suppliers as well as customers. We recognise the fact that the stronger the relationships with suppliers the more we are able to serve our customers better. We remain committed to all our stakeholder for ethical business practices. The Company has put in practice a code of business conduct and ethics (CoBE) and every employee at Cirrus is required to comply with its principles.


Cirrus Research plc (Registered number: 00987160)

Strategic Report
for the year ended 30th June 2025

The impact of the company's operations on the community and environment
At Cirrus, we are committed to lowering our impact on the environment. We have a strong commitment to providing sustainable supplies and, wherever possible, will procure locally both to benefit the environment and local businesses.

The desirability of the company maintaining a reputation for high standards of business conduct
Cirrus's Board periodically reviews their Corporate Governance requirements as the commitment to upholding the highest standards are set at board level but is filtered down throughout the whole group organisation.

The need to act fairly as between members of the company
The Directors consider and focus its attention to ensure that the company's performance is in line with their strategic vision for both the short- and long-term objectives. The impact of this on all of the stakeholders is reviewed. The Directors believe they act fairly.

The Board has created a culture of honesty, integrity and respect of the Cirrus's core values and principles. The company has set a number of guidelines on Code of Business Conduct and Ethics (COBE) through to various Environment and Employment policies.

Principal decisions
We define principal decisions taken by the Board as those decisions in 2024/25 that are of a strategic nature and that are significant to any of our key stakeholder groups.


STREAMLINED ENERGY AND CARBON REPORTING
Total Usage Total Usage Conversion Total Emissions
Site Fuel Type Floor Area m2 L KWH Factor T/CO2e
Acoustic House Electric 660.77 48,564 0.17700 8.60
Acoustic House Oil - 2.54014 -

Methodology
1. The total electricity usage is based on billed amounts
2. Floor area is based on both ground and first floor space
3. Conversion factors are the current government published values
4. The company has only one operational site as listed above

Comparative - Year Ended 31st March 2024

Total Usage Total Usage Conversion Total Emissions
Site Fuel Type Floor Area m2 L KWH Factor T/CO2e
Acoustic House Electric 660.77 70,182 0.20705 14.53
Acoustic House Oil 4,865 2.54014 12.36

Actions taken
The company continually reviews any new ways to make energy usage improvements when replacing equipment and fittings.


Cirrus Research plc (Registered number: 00987160)

Strategic Report
for the year ended 30th June 2025

FUTURE DEVELOPMENTS AND STRATEGY
The organisation is undertaking a significant investment in the implementation of a group-wide Enterprise Resource Planning (ERP) system. This initiative is intended to enhance operational efficiency and standardise inter-company processes. Preliminary market research into potential solutions has been completed, and implementation is scheduled for April 2026. The associated costs of system procurement, customisation, and workforce training represent a material investment for the business.

In parallel, several new product developments are approaching completion, with commercial launches planned for the forthcoming financial period. Notably, one product addresses a gap within the current portfolio, with early indications of strong interest from key customers and distribution partners, particularly in international markets.

The introduction of these products will serve as the foundation for a broader product innovation program, which is in the early planning stages. This initiative will leverage emerging technologies to establish a sustainable new product development pipeline.

Additionally, the business continues to actively pursue acquisition opportunities in complementary markets, specifically those aligned with noise-related technologies and solutions.

ON BEHALF OF THE BOARD:





D S Wallis - Director


8th December 2025

Cirrus Research plc (Registered number: 00987160)

Report of the Directors
for the year ended 30th June 2025

The directors present their report with the financial statements of the company for the year ended 30th June 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of development, manufacture and sale of electro acoustic measuring equipment for professional use.

DIVIDENDS
Interim dividends totalling 23.684p per share were paid during the year. The directors recommend that no final dividend be paid.

The total distribution of dividends for the year ended 30th June 2025 will be £ 225,000 .

FUTURE DEVELOPMENTS
These details have been provided in the company's strategic report.

DIRECTORS
The directors set out in the table below have held office during the whole of the period from 1st July 2024 to the date of this report unless otherwise stated.

Other changes in directors holding office are as follows:

G B Quaglia - resigned 30/4/25

The directors shown below were in office at 30th June 2025 but did not hold any interest in the Ordinary shares of £1 each at 1st July 2024 or 30th June 2025.

K D Frankish
D S Wallis
L M Wallis

FINANCIAL RISK MANAGEMENT
These details are provided in the company's strategic report.

CREDITORS
The Company's policy is to make payment to suppliers in accordance with the terms of payment agreed at the time the contract of supply is made.

The company's creditors days at the year-end based upon the average daily amount invoiced by suppliers were 47 days.

ENGAGEMENT WITH EMPLOYEES
These details have been provided in the company's Section 172 (1) statement which is included in the strategic report.

ENGAGEMENT WITH SUPPLIERS, CUSTOMERS AND OTHERS
These details have been provided in the company's Section 172 (1) statement which is included in the strategic report.


Cirrus Research plc (Registered number: 00987160)

Report of the Directors
for the year ended 30th June 2025

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the
financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Sadofskys, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





D S Wallis - Director


8th December 2025

Report of the Independent Auditors to the Members of
Cirrus Research plc

Opinion
We have audited the financial statements of Cirrus Research plc (the 'company') for the year ended 30th June 2025 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30th June 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Cirrus Research plc


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Cirrus Research plc


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of electro acoustic measuring equipment;
- we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including Companies Act 2006, taxation legislation, data protection, anti-bribery, employment, environmental and health and safety legislation;
- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and
- identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud;
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected relationships;
- tested journal entries to identify unusual transactions;
- assessed whether judgements and assumptions made in determining the accounting estimates set out in [note 2] were indicative of potential bias;
- investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- reading the minutes of meetings of those charged with governance;
- enquiring of management as to actual and potential litigation and claims;
- reviewing correspondence with HMRC, relevant regulators and the company's legal advisors.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Cirrus Research plc


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Alan Brocklehurst (Senior Statutory Auditor)
for and on behalf of Sadofskys
Statutory Auditors
Princes House
Wright Street
Hull
East Yorkshire
HU2 8HX

8th December 2025

Cirrus Research plc (Registered number: 00987160)

Statement of Comprehensive
Income
for the year ended 30th June 2025

2025 2024
Notes £    £   

TURNOVER 3 6,081,043 4,877,275

Cost of sales 3,448,093 3,061,566
GROSS PROFIT 2,632,950 1,815,709

Administrative expenses 2,058,064 1,892,536
574,886 (76,827 )

Other operating income 72,915 81,774
OPERATING PROFIT 5 647,801 4,947

Interest receivable and similar income 9,921 8,185
657,722 13,132

Interest payable and similar expenses 7 - 7
PROFIT BEFORE TAXATION 657,722 13,125

Tax on profit 8 10,150 (1,790 )
PROFIT FOR THE FINANCIAL YEAR 647,572 14,915

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR
THE YEAR

647,572

14,915

Cirrus Research plc (Registered number: 00987160)

Balance Sheet
30th June 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 10 1 1
Tangible assets 11 135,028 197,385
Investments 12 45,274 45,274
180,303 242,660

CURRENT ASSETS
Stocks 13 847,682 1,037,271
Debtors 14 1,304,933 981,451
Cash at bank and in hand 913,628 464,608
3,066,243 2,483,330
CREDITORS
Amounts falling due within one year 15 536,050 464,376
NET CURRENT ASSETS 2,530,193 2,018,954
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,710,496

2,261,614

PROVISIONS FOR LIABILITIES 17 26,310 -
NET ASSETS 2,684,186 2,261,614

CAPITAL AND RESERVES
Called up share capital 18 950,000 950,000
Retained earnings 19 1,734,186 1,311,614
SHAREHOLDERS' FUNDS 2,684,186 2,261,614

The financial statements were approved by the Board of Directors and authorised for issue on 8th December 2025 and were signed on its behalf by:





D S Wallis - Director


Cirrus Research plc (Registered number: 00987160)

Statement of Changes in Equity
for the year ended 30th June 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1st July 2023 950,000 1,296,699 2,246,699

Changes in equity
Total comprehensive income - 14,915 14,915
Balance at 30th June 2024 950,000 1,311,614 2,261,614

Changes in equity
Dividends - (225,000 ) (225,000 )
Total comprehensive income - 647,572 647,572
Balance at 30th June 2025 950,000 1,734,186 2,684,186

Cirrus Research plc (Registered number: 00987160)

Cash Flow Statement
for the year ended 30th June 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 632,792 (134,475 )
Interest paid - (7 )
Tax paid - (279 )
Taxation refund received 20,355 -
Net cash from operating activities 653,147 (134,761 )

Cash flows from investing activities
Purchase of tangible fixed assets (21,232 ) (63,995 )
Sale of tangible fixed assets 25,736 -
Interest received 9,921 8,185
Net cash from investing activities 14,425 (55,810 )

Cash flows from financing activities
Loans movement with group companies 6,448 28,552
Equity dividends paid (225,000 ) -
Net cash from financing activities (218,552 ) 28,552

Increase/(decrease) in cash and cash equivalents 449,020 (162,019 )
Cash and cash equivalents at beginning of year 2 464,608 626,627

Cash and cash equivalents at end of year 2 913,628 464,608

Cirrus Research plc (Registered number: 00987160)

Notes to the Cash Flow Statement
for the year ended 30th June 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
Profit before taxation 657,722 13,125
Depreciation charges 46,539 53,356
Loss on disposal of fixed assets 11,314 43
Finance costs - 7
Finance income (9,921 ) (8,185 )
705,654 58,346
Decrease/(increase) in stocks 189,589 (302,342 )
(Increase)/decrease in trade and other debtors (329,930 ) 295,972
Increase/(decrease) in trade and other creditors 67,479 (186,451 )
Cash generated from operations 632,792 (134,475 )

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30th June 2025
30/6/25 1/7/24
£    £   
Cash and cash equivalents 913,628 464,608
Year ended 30th June 2024
30/6/24 1/7/23
£    £   
Cash and cash equivalents 464,608 626,627


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1/7/24 Cash flow At 30/6/25
£    £    £   
Net cash
Cash at bank and in hand 464,608 449,020 913,628
464,608 449,020 913,628
Total 464,608 449,020 913,628

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements
for the year ended 30th June 2025

1. STATUTORY INFORMATION

Cirrus Research plc is a private company , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Cirrus Research plc as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax.

Sale of goods are recognised when the goods are delivered.

Service sales are recognised when the product has been repaired or serviced and returned to the customer.

Intangible assets
Intangible assets are measured at cost.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 5% on cost
Plant and machinery - 15% on cost
Fixtures and fittings - 15% on cost
Motor vehicles - 25% on cost
Computer equipment - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Stock is on a first in first out basis.


Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. Contributions payable for the year are charged in the profit and loss account.

Going concern
The directors are fully committed to ensuring that the company is adequately funded to enable it to achieve its objectives and be well placed to manage its business risks successfully despite the current heightened uncertain economic outlook.

The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the annual financial statements.

Further information regarding the company's business activities, together with the factors likely to affect its future development, performance and position is set out in the Strategic Report.

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

3. TURNOVER

An analysis of turnover by geographical market is given below :

20252024

Sales - United Kingdom2,802,8733,142,438
Sales - Europe1,831,663538,745
Sales - Rest of World1,446,5071,196,093
6,081,0434,877,275

4. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 1,677,613 1,699,104
Social security costs 161,176 159,891
Other pension costs 134,355 161,540
1,973,144 2,020,535

The average number of employees during the year was as follows:
2025 2024

Office and Administration 30 27
Test and Production 10 11
Research and Development 6 7
46 45

2025 2024
£    £   
Directors' remuneration 235,877 212,520

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 1 1

Information regarding the highest paid director is as follows:
2025 2024
£    £   
Emoluments etc 98,577 98,577

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2025 2024
£    £   
Depreciation - owned assets 46,539 53,356
Loss on disposal of fixed assets 11,314 43
Auditors' remuneration 9,500 9,000
Foreign exchange differences (37,915 ) (51,774 )

6. EXCEPTIONAL ITEMS
2025 2024
£    £   
Exceptional items - (23,608 )

Exceptional items relate to a loan within the group which will not be recovered by the company.

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Interest on corporation tax - 7

8. TAXATION

Analysis of the tax charge/(credit)
The tax charge/(credit) on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 4,195 -
Prior year taxation (20,355 ) (1,790 )
Total current tax (16,160 ) (1,790 )

Deferred taxation 26,310 -
Tax on profit 10,150 (1,790 )

9. DIVIDENDS
2025 2024
£    £   
Interim 225,000 -

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

10. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1st July 2024
and 30th June 2025 1
NET BOOK VALUE
At 30th June 2025 1
At 30th June 2024 1

11. TANGIBLE FIXED ASSETS
Fixtures
Long Plant and and
leasehold machinery fittings
£    £    £   
COST
At 1st July 2024 153,667 266,179 88,881
Additions - 3,250 5,997
Disposals - - -
At 30th June 2025 153,667 269,429 94,878
DEPRECIATION
At 1st July 2024 76,808 248,054 77,609
Charge for year 7,699 5,893 3,845
Eliminated on disposal - - -
At 30th June 2025 84,507 253,947 81,454
NET BOOK VALUE
At 30th June 2025 69,160 15,482 13,424
At 30th June 2024 76,859 18,125 11,272

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

11. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1st July 2024 81,434 293,847 884,008
Additions - 11,985 21,232
Disposals (45,600 ) - (45,600 )
At 30th June 2025 35,834 305,832 859,640
DEPRECIATION
At 1st July 2024 19,001 265,151 686,623
Charge for year 8,959 20,143 46,539
Eliminated on disposal (8,550 ) - (8,550 )
At 30th June 2025 19,410 285,294 724,612
NET BOOK VALUE
At 30th June 2025 16,424 20,538 135,028
At 30th June 2024 62,433 28,696 197,385

12. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1st July 2024
and 30th June 2025 45,274
NET BOOK VALUE
At 30th June 2025 45,274
At 30th June 2024 45,274

The company's investments at the Balance Sheet date in the share capital of companies include the following:


Cirrus Research France SAS
Registered office: 679 avenue de la Republique, 59800 Lille, France
Nature of business: Engineering and technical sales and studies
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves (48,994 ) (17,418 )
Loss for the year (36,212 ) (43,467 )

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

12. FIXED ASSET INVESTMENTS - continued

Cirrus Research GmbH
Registered office: Rennbahnstraße 72-74, 60528 Frankfurt am Main, Germany
Nature of business: Sales and distribution company
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves 5,525 (26,663 )
Profit/(loss) for the year 22,166 (102,203 )

All companies above are not consolidated within these accounts as the company has taken advantage of the exemption shown within the accounting policies.

13. STOCKS
2025 2024
£    £   
Raw materials 378,599 467,270
Finished goods 469,083 570,001
847,682 1,037,271

14. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 981,017 681,820
Amounts owed by group undertakings 4,561 11,009
Other debtors 184,695 189,486
Prepayments and accrued income 134,660 99,136
1,304,933 981,451

15. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 326,475 231,181
Taxation 4,195 -
Social security and other taxes 60,103 89,132
Other creditors 9,718 7,912
Accrued expenses 135,559 136,151
536,050 464,376

Cirrus Research plc (Registered number: 00987160)

Notes to the Financial Statements - continued
for the year ended 30th June 2025

16. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year 48,167 48,046
Between one and five years 132,740 126,407
In more than five years 27,500 57,500
208,407 231,953

17. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred taxation 26,310 -

Deferred
tax
£   
Charge to Statement of Comprehensive Income during year 26,310
Balance at 30th June 2025 26,310

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
950,000 Ordinary £1 950,000 950,000

Ordinary share capital includes full rights on voting dividends and repayment of capital.

19. RESERVES
Retained
earnings
£   

At 1st July 2024 1,311,614
Profit for the year 647,572
Dividends (225,000 )
At 30th June 2025 1,734,186

20. ULTIMATE PARENT COMPANY

The company's entire share capital is owned by Scientific Measurements Limited, a company registered in England and Wales (Reg No. 14861997).